Status:

COMPLETED

Health Economy Register

Lead Sponsor:

Cankado GmbH

Collaborating Sponsors:

Amgen

Conditions:

Breast Neoplasms

Eligibility:

All Genders

18+ years

Brief Summary

In breast oncology, the increasing number of oral and intravenous drug therapies pose great challenges for patient management. Numerous studies demonstrate that well-informed patients develop higher c...

Eligibility Criteria

Inclusion

  • Men and women with breast cancer
  • Ongoing medical drug treatment
  • 18 years or older
  • CANKADO account

Exclusion

  • Lack of consent to study participation or lack of patient's ability to stuconsent

Key Trial Info

Start Date :

July 5 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2020

Estimated Enrollment :

219 Patients enrolled

Trial Details

Trial ID

NCT04386629

Start Date

July 5 2019

End Date

December 31 2020

Last Update

February 8 2021

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Hämato-onkologischer Studienkreis am Klinikum Aschaffenburg

Aschaffenburg, Germany, 63739

2

Kliniken der Stadt Köln - Krankenhaus Holweide, Brustzentrum

Cologne, Germany, 51067

3

Kliniken Essen Mitte

Essen, Germany, 45136

4

Onkology Bethanien Frankfurt

Frankfurt, Germany, 60389